HIV Salvage Therapy: Research

Dolutegravir Appears Superior to Raltegravir Among HIV Salvage Patients (March 11, 2013)
From AIDSmeds.com
How Can "JAK Inhibitors" Help Salvage Patients and the Search for an HIV Cure? A Blog Entry by Nelson Vergel, B.S.Ch.E., M.B.A. (January 15, 2013)
An interview with Raymond Schinazi, Ph.D., D.Sc.
From TheBodyPRO.com
Dropping Inactive NRTI Does Not Compromise 4- or 5-Drug Salvage Combos (September 21, 2011)
From National AIDS Treatment Advocacy Project
Health Care Provider Survey: Looking for HIV+ Patients With No Remaining HIV Treatment Options (September 16, 2011)
Search currently limited to patients in the NY-CT-MA-NJ-PA areas of the U.S.
From AIDS Community Research Initiative of America
How You Can Help Your Patients Who Are Running Out of HIV Treatment Options: A Blog Entry by Nelson Vergel, B.S.Ch.E., M.B.A. (July 6, 2011)
From TheBodyPRO.com
Is There a Future for HIV-Infected Patients in "Deep Salvage"? A Blog Entry by Nelson Vergel, B.S.Ch.E., M.B.A. (May 3, 2011)
From TheBodyPRO.com
Management of Treatment-Experienced Patients: A Summary of Key CROI 2008 Research (February 11, 2008)
In 15th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
Another Look at TITAN and DUET: How Will They Change Clinical Practice? (July 25, 2007)
In The 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBodyPRO.com
Efficacy and Safety of Darunavir-Ritonavir Compared With That of Lopinavir-Ritonavir at 48 Weeks in Treatment-Experienced, HIV-Infected Patients in TITAN: A Randomised Controlled Phase III Trial (July 7, 2007)
Study shows greater viral suppression among darunavir patients after 48 weeks.
In The Lancet
Adding Etravirine to Darunavir/Ritonavir Improves Virologic Suppression, DUET Studies Show (July 6, 2007)
From aidsmap.com

VIEW ALL ARTICLES

MOST VIEWED ARTICLES

	HIV Management Today: Mental Health & HIV, the Uncharted Territory
	Danish Study Targets HIV Reservoir, in Latest Search for HIV Cure
	CROI 2013: Research on Aging and HIV (Video)
	PrEP Failures and Successes: One Study Whose Impact Will Last Well Beyond CROI 2013
	10 Top Studies Whose Impact Will Last Well Beyond CROI 2013
	HIV Opportunistic Infection Guidelines Updated

More Most Viewed Articles

TheBodyPRO.com is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.